Workboat Indexes
Press Releases about Immunogen Inc
![](https://mms.businesswire.com/media/20230201005203/en/1701642/22/imgnlogo.jpg)
ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences
February 01, 2023
From ImmunoGen, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230104005886/en/1677171/22/download.jpg)
From ImmunoGen, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230104005094/en/1675386/22/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20221228005248/en/1673390/22/imgnlogo.jpg)
From ImmunoGen, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20221227005216/en/1673116/22/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20221210005003/en/1660510/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20221209005072/en/1660076/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20221201005260/en/1651957/5/imgnlogo.jpg)
From ImmunoGen, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20221121005078/en/1643020/5/imgnlogo.jpg)
From ImmunoGen, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20221104005657/en/1626742/5/Elahere_TM-Full_Logo-GYNX_Pantone.jpg)
![](https://mms.businesswire.com/media/20221104005146/en/1625637/5/imgnlogo.jpg)
From ImmunoGen, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20221101006101/en/1621192/5/imgnlogo.jpg)
From ImmunoGen, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20221101005423/en/1619979/5/imgnlogo.jpg)
ImmunoGen Announces Departure of Chief Commercial Officer
November 01, 2022
From ImmunoGen, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20221028005044/en/1617178/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20221020005187/en/1607787/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20221003005247/en/1588990/5/imgnlogo.jpg)
From ImmunoGen, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220929005074/en/1585879/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220914005874/en/1572023/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220911005025/en/1567287/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220901005165/en/1558833/5/imgnlogo.jpg)
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 01, 2022
From ImmunoGen, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220831005279/en/1557731/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220801005570/en/1530532/5/imgnlogo.jpg)
From ImmunoGen, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220729005054/en/1528747/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220714005101/en/1512776/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220701005068/en/1502872/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220613005142/en/1483547/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220601005360/en/1472243/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220526005719/en/1468861/5/imgnlogo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.